WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002005844) PROTEIN COMPLEX SERVING AS A VEHICLE FOR ORALLY ADMINISTERABLE MEDICAMENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/005844    International Application No.:    PCT/DE2001/002816
Publication Date: 24.01.2002 International Filing Date: 19.07.2001
Chapter 2 Demand Filed:    14.01.2002    
IPC:
A61K 38/28 (2006.01), A61K 38/48 (2006.01), A61K 39/08 (2006.01), A61K 47/48 (2006.01)
Applicants: BIOTECON GESELLSCHAFT FÜR BIOTECHNOLOGISCHE ENTWICKLUNG UND CONSULTING MBH [DE/DE]; Hermannswerder Haus 17, 14473 Potsdam (DE) (For All Designated States Except US).
BIGALKE, Hans [DE/DE]; (DE) (For US Only).
FREVERT, Jürgen [DE/DE]; (DE) (For US Only)
Inventors: BIGALKE, Hans; (DE).
FREVERT, Jürgen; (DE)
Agent: BETTENHAUSEN, Berthold; Dehmel & Bettenhausen, Müllerstr. 1, 80469 München (DE)
Priority Data:
100 35 156.5 19.07.2000 DE
100 35 155.7 19.07.2000 DE
Title (DE) PROTEINKOMPLEX ALS VEHIKEL FÜR ORAL VERFÜGBARE ARZNEIMITTEL
(EN) PROTEIN COMPLEX SERVING AS A VEHICLE FOR ORALLY ADMINISTERABLE MEDICAMENTS
(FR) COMPLEXE PROTEIQUE SERVANT DE VEHICULE POUR MEDICAMENTS ADMINISTRABLES PAR VOIE ORALE
Abstract: front page image
(DE)Die vorliegende Erfindung betrifft einen Proteinkomplex, umfassend ein oder mehrere Komplexproteine oder Derivate aus Clostridium botulinum Typ A, B, C¿1?, C¿2?, D, E, F oder G und ein ausgewähltes Polypeptid oder niedermolekulares Pharmakon.
(EN)The invention relates to a protein complex comprising one or more complex proteins or derivatives extracted from Clostridium botulinum of type A, B, C¿1?, C¿2?, D, E, F or G, and a selected polypeptide or low-molecular pharmacon.
(FR)L'invention concerne un complexe protéique comprenant une ou plusieurs protéines complexes constituées de <i>Clostridium botulinum</i> de type A, B, C¿1?, C¿2?, D, E, F ou G, ou des dérivés de ces derniers, et un polypeptide sélectionné ou un produit pharmaceutique à bas poids moléculaire.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)